Clinical Trial Update: Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating isavuconazole for renally impaired patients with invasive aspergillosis and rare fungal infections; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis
• Invasive Fungal Infections

Drugs mentioned

• Isavuconazole (Isavuconazole)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Aspergillosis, Invasive Fungal Infections | Phase 3 | Status: COMPLETED | Results posted: 2016-01-11